WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--GARDASIL® [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine], Merck's vaccine for the prevention of cervical cancer, received the Prix Galien USA 2007 Award for Best Biotechnology product, Merck & Co., Inc. announced today. In addition, JANUVIATM (sitagliptin), the Company's treatment of type 2 diabetes, received the 2007 Award for Best Pharmaceutical Agent. Both were presented at a ceremony in New York City on Sept. 25.
